Pay in 4 interest-free payments of $25.12 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
and Sarah E
display and in meetings
We might find it exciting and temporarily rewarding to gamble on the lottery or impulsively buy an expensive gadget
Programme Director for the Modular PGCE at Christ Church and also an independent education consultant and active member of the Association for Science Education (ASE)
and Indian fighter John B
Melanoma LNFB and Sarah E: This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of melanoma treatment. Due to recent drug approvals and increasing ability to offer combined agents, there are many more treatment options available to melanoma patients than even a few years ago. Especially significant are the recent FDA approval of the immunotherapeutic agent ipilimumab for metastatic melanoma, and new agents
US$ 29.90
US$ 10.00
US$ 25.00
US$ 11.99
US$ 25.00
US$ 144.95
US$ 29.90
